102 related articles for article (PubMed ID: 20524053)
21. Estrogen receptor beta polymorphism is associated with prostate cancer risk.
Thellenberg-Karlsson C; Lindström S; Malmer B; Wiklund F; Augustsson-Bälter K; Adami HO; Stattin P; Nilsson M; Dahlman-Wright K; Gustafsson JA; Grönberg H
Clin Cancer Res; 2006 Mar; 12(6):1936-41. PubMed ID: 16551880
[TBL] [Abstract][Full Text] [Related]
22. Polymorphic markers in the SRD5A2 gene and prostate cancer risk: a population-based case-control study.
Hsing AW; Chen C; Chokkalingam AP; Gao YT; Dightman DA; Nguyen HT; Deng J; Cheng J; Sesterhenn IA; Mostofi FK; Stanczyk FZ; Reichardt JK
Cancer Epidemiol Biomarkers Prev; 2001 Oct; 10(10):1077-82. PubMed ID: 11588134
[TBL] [Abstract][Full Text] [Related]
23. A case-control study of risk factors for prostate cancer in Iran.
Hosseini M; SeyedAlinaghi S; Mahmoudi M; McFarland W
Acta Med Iran; 2010; 48(1):61-6. PubMed ID: 21137672
[TBL] [Abstract][Full Text] [Related]
24. Circulating vitamin D metabolites in relation to subsequent development of prostate cancer.
Gann PH; Ma J; Hennekens CH; Hollis BW; Haddad JG; Stampfer MJ
Cancer Epidemiol Biomarkers Prev; 1996 Feb; 5(2):121-6. PubMed ID: 8850273
[TBL] [Abstract][Full Text] [Related]
25. Dietary patterns identified using factor analysis and prostate cancer risk: a case control study in Western Australia.
Ambrosini GL; Fritschi L; de Klerk NH; Mackerras D; Leavy J
Ann Epidemiol; 2008 May; 18(5):364-70. PubMed ID: 18261927
[TBL] [Abstract][Full Text] [Related]
26. Serum enterolactone concentration is not associated with prostate cancer risk in a nested case-control study.
Kilkkinen A; Virtamo J; Virtanen MJ; Adlercreutz H; Albanes D; Pietinen P
Cancer Epidemiol Biomarkers Prev; 2003 Nov; 12(11 Pt 1):1209-12. PubMed ID: 14652283
[TBL] [Abstract][Full Text] [Related]
27. Endogenous sex hormones and prostate cancer risk: a case-control study nested within the Carotene and Retinol Efficacy Trial.
Chen C; Weiss NS; Stanczyk FZ; Lewis SK; DiTommaso D; Etzioni R; Barnett MJ; Goodman GE
Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1410-6. PubMed ID: 14693730
[TBL] [Abstract][Full Text] [Related]
28. Alcohol and the risk of prostate cancer and benign prostatic hyperplasia.
Crispo A; Talamini R; Gallus S; Negri E; Gallo A; Bosetti C; La Vecchia C; Dal Maso L; Montella M
Urology; 2004 Oct; 64(4):717-22. PubMed ID: 15491708
[TBL] [Abstract][Full Text] [Related]
29. Antidiabetic medication and prostate cancer risk: a population-based case-control study.
Murtola TJ; Tammela TL; Lahtela J; Auvinen A
Am J Epidemiol; 2008 Oct; 168(8):925-31. PubMed ID: 18700234
[TBL] [Abstract][Full Text] [Related]
30. Mass screening-based case-control study of diet and prostate cancer in Changchun, China.
Li XM; Li J; Tsuji I; Nakaya N; Nishino Y; Zhao XJ
Asian J Androl; 2008 Jul; 10(4):551-60. PubMed ID: 18478158
[TBL] [Abstract][Full Text] [Related]
31. Prediagnostic plasma vascular endothelial growth factor levels and risk of prostate cancer.
Li H; Kantoff PW; Ma J; Stampfer MJ; George DJ
Cancer Epidemiol Biomarkers Prev; 2005 Jun; 14(6):1557-61. PubMed ID: 15941972
[TBL] [Abstract][Full Text] [Related]
32. Familial prostate cancer in Sweden. A nationwide register cohort study.
Grönberg H; Damber L; Damber JE
Cancer; 1996 Jan; 77(1):138-43. PubMed ID: 8630920
[TBL] [Abstract][Full Text] [Related]
33. Vasectomy and risk of prostate cancer.
Stanford JL; Wicklund KG; McKnight B; Daling JR; Brawer MK
Cancer Epidemiol Biomarkers Prev; 1999 Oct; 8(10):881-6. PubMed ID: 10548316
[TBL] [Abstract][Full Text] [Related]
34. Prostate cancer and vasectomy: a hospital-based case-control study in China, Nepal and the Republic of Korea.
Schwingl PJ; Meirik O; Kapp N; Farley TM;
Contraception; 2009 May; 79(5):363-8. PubMed ID: 19341848
[TBL] [Abstract][Full Text] [Related]
35. Effects of prostate-specific antigen testing on familial prostate cancer risk estimates.
Bratt O; Garmo H; Adolfsson J; Bill-Axelson A; Holmberg L; Lambe M; Stattin P
J Natl Cancer Inst; 2010 Sep; 102(17):1336-43. PubMed ID: 20724726
[TBL] [Abstract][Full Text] [Related]
36. Plasma selenium level before diagnosis and the risk of prostate cancer development.
Brooks JD; Metter EJ; Chan DW; Sokoll LJ; Landis P; Nelson WG; Muller D; Andres R; Carter HB
J Urol; 2001 Dec; 166(6):2034-8. PubMed ID: 11696701
[TBL] [Abstract][Full Text] [Related]
37. Cigarette smoking and risk of prostate cancer in middle-aged men.
Plaskon LA; Penson DF; Vaughan TL; Stanford JL
Cancer Epidemiol Biomarkers Prev; 2003 Jul; 12(7):604-9. PubMed ID: 12869398
[TBL] [Abstract][Full Text] [Related]
38. Reduced risk of prostate cancer in men who are childless as compared to those who have fathered a child: a population based case-control study.
Giwercman A; Richiardi L; Kaijser M; Ekbom A; Akre O
Int J Cancer; 2005 Jul; 115(6):994-7. PubMed ID: 15729731
[TBL] [Abstract][Full Text] [Related]
39. Are infertile men less healthy than fertile men? Results of a prospective case-control survey.
Salonia A; Matloob R; Gallina A; Abdollah F; Saccà A; Briganti A; Suardi N; Colombo R; Rocchini L; Guazzoni G; Rigatti P; Montorsi F
Eur Urol; 2009 Dec; 56(6):1025-31. PubMed ID: 19297076
[TBL] [Abstract][Full Text] [Related]
40. Anogenital distance and the risk of prostate cancer.
Castaño-Vinyals G; Carrasco E; Lorente JA; Sabaté Y; Cirac-Claveras J; Pollán M; Kogevinas M
BJU Int; 2012 Dec; 110(11 Pt B):E707-10. PubMed ID: 22984847
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
